Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Summary of Revenue

For the years ended December 31, 2022, 2021 and 2020, revenue comprised the following:

	Year Ended December 31,
(in thousands)	2022		2021		2020
Prescription transactions revenue	$	550,536	$	593,359	$	488,257
Pharma manufacturer solutions revenue (1)		99,425		73,348		20,488
Subscription revenue		96,167		59,925		29,386
Other revenue		20,426		18,792		12,569
Total revenue	$	766,554	$	745,424	$	550,700

(1)Pharma manufacturer solutions revenue is presented separately from other revenue beginning in 2022. Prior period amounts have been recast to conform with the current period presentation.